A2 milk set for bumper profit
Earnings driven mostly by A2 Milk's success in China's infant formula market.
Earnings driven mostly by A2 Milk's success in China's infant formula market.
A2 Milk's net profit shot up by 65 per cent in the first four months.
Full menu for a2 Milk's annual shareholder meeting across the Tasman.
Big increases in earnings are expected from the latest round of results.
Fletcher Building, which was rumoured to be leaving, stayed in the index.
COMMENT: For a2 Milk, much depends on how it performs in China.
A2 Milk has emerged as a key driver of the total share market.
How did a tiny business transform itself into the NZ sharemarket's most valuable company?
Market cap of $8.6 billion, well ahead of the next biggest Auckland Airport.
A2 Milk's net profit in four months to October up 137.7pc to $52.4m.
A2 Milk the best performer after it met investor hopes at its annual meeting.
Z Energy, A2 Milk and Metro Glass shares also make gains.
A2 Milk, top-performing stock on NZX 50 in 2017, cites 'pleasing' start of 2018 FY.
A2, Synlait drop more than 20% from recent highs, dragging index lower.
Our take on what is happening on the markets this week.
Synlait gains manufacturer registration for a2 Milk's China label infant formula.
NZ Refining stock falls amid pipeline repiar, while Synlait retreats from high.
A2 Milk Co lifted annual sales guidance for the second time in as many months.
Expert says Fisher & Paykel Healthcare and A2 popular.
Synlait Milk posted a 3.8 per cent lift in first-half profit.
Friesland Compina will sell its 8.17 per cent stake in Canterbury's Synlait Milk to a2 Milk.
A2 Milk stock falls as firm's CEO and chair sell shares.
A2 Milk Co's chief executive and chair have sold down their stakes less than a week after reporting first-half profit more than tripled.
A2 Milk more than tripled its first-half profit as demand for its A2 Platinum infant formula surged in its key Australia, NZ and China businesses.
A2 Milk jumps as Bellamy's cuts revenue forecast.
Bellamy's Australia shares took a nose dive after it cut its profit forecast for a second time, announced chief executive Laura McBain is leaving the company, and tweaked the terms of its supply contract with Fonterra.